OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5

olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
$1.3751per EA

Strength

10; 12.5; 40 mg/1; mg/1; mg/1

Manufacturer

Endo USA Inc.

NDC

49884078911

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA206137

On Market Since

10/26/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines
Increased Diuresis
Thiazide Diuretic
Thiazides

Price History

1W

0.0%

1M

+9.4%

3M

-1.5%

6M

-3.9%

1Y

+15.9%

3Y

-9.6%

5Y

-31.2%

All

-55.6%